The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

At no point on Thursday did anyone from the administration mention Medicare drug price negotiations, a key part of the Inflation Reduction Act which allows federal officials to negotiate the price of ...

Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back ...

WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price ...

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

By Patrick Wingrove and Puyaan Singh (Reuters) -AbbVie said on Friday the Trump administration was pushing for steeper cuts ...

Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the active ingredient in ...

The Biden administration is working on forcing the pharmaceutical industry to lower the cost of popular drugs for Medicare Part D recipients. A federal judge has ruled against the pharmaceutical ...

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

Topping the list are Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, which are considered one product in the talks since they all share the ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...